Sterling Biotech Limited, a active public limited company, was established on 23 March 1985 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L51900MH1985PLC035738. Registered under ROC Roc Mumbai. it is listed on BSE: 512299. It has an authorized capital of ₹2,800.00 Cr and a paid-up capital of ₹643.35 Cr.
Formerly known as Sterling Tea & Indutries Limited, Pluto Exports & Consultants Limited. It upholds a compliant status. In 2024, it reported revenue of ₹476.71 Cr and a net worth of ₹879.42 Cr. Employing 249 professional, Its leadership includes Alok Kumar Garg (Nominee Director), Monisha Prabhu Macedo (Nominee Director), Vishal Jyotindra Gor (Nominee Director). Past directors included Rama Subramaniam Gandhi, Narayan Tripunithura Mahadeva, Perumal Gandhi. It holds ₹703.90 Cr open charges and ₹21,758.44 Cr settled loans. Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No. 601, Windfall Building,, Sahar Plaza Complex, Near Hotel Kohinoor, (Andheri East), Mumbai, Maharashtra, 400059.
L51900MH1985PLC035738
035738
23 March 1985
₹2,800.00 Cr
₹643.35 Cr
Roc Mumbai
Listed (BSE: 512299)
Active
Explore comprehensive insights into Sterling Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alok Kumar Garg | Nominee Director | 29 Aug 2024 | Current |
| Monisha Prabhu Macedo | Nominee Director | 24 Mar 2025 | Current |
| Vishal Jyotindra Gor | Nominee Director | 29 Aug 2024 | Current |
| Aftab Mathur | Nominee Director | 25 Jun 2025 | Current |
| Keyur Anilkumar Parekh | Nominee Director | 29 Aug 2024 | Current |
| Philip Chacko Mundanilkunnathil | Ceo | 24 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2023 | Past |
| Pramod Abcsdd | Director | 24 Dec 2024 | Past |
| Pramod Abcsdd | Director | 10 Oct 2024 | Past |
| Pramod Abcsdd | Director | 29 Aug 2024 | Past |
| Pramod Abcsdd | Director | 08 Sep 2021 | Past |
| Pramod Abcsdd | Managing Director | 17 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sterling Biotech Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.51% increase. The company also saw a substantial fall in profitability, with a 100.32% decrease in profit. The company's net worth dipped by a decrease of 2.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sterling Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,039,000,000.00
₹217,584,414,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2025 | Others | ₹95.00 Cr | Open |
| 18 Sep 2025 | Others | ₹572.00 Cr | Open |
| 28 Nov 2023 | State Bank Of India | ₹22.50 Cr | Open |
| 19 Oct 2023 | Hdfc Bank Limited | ₹14.40 Cr | Open |
| 03 Oct 2023 | Others | ₹24.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Sterling Biotech has a workforce of 249 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sterling Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterling Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nikita Ashok Suyani was appointed as a Company Secretary was appointed as a Company Secretary on 15 Dec 2025 & has been associated with this company since 1 month 1 day . was recorded as a recent event.
A charge with Others amounted to Rs. 95.00 Cr with Charge ID 101161944 was registered on 18 Sep 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 572.00 Cr with Charge ID 101161938 was registered on 18 Sep 2025. was documented.
Progress on Sterling Biotech Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was documented.
Progress on Anil Shantilal Inani was appointed as a Cfo was appointed as a Cfo on 16 Jul 2025 & has been associated with this company since 6 months 3 days . was documented.
The activity Aftab Mathur was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jun 2025 & has been associated with this company since 6 months 24 days . was completed.
Sterling Biotech, a debt-ridden company, can now be taken back by its promoters if they pay the full amount owed to lenders. This ruling may set a precedent for other companies in insolvency. The NCLAT has allowed the withdrawal of a petition filed under the Insolvency and Bankruptcy Code. The promoters must pay the lenders directly, not through the company's assets. The Sterling group owes a total of Rs 15,000 crore to creditors. The promoters are currently absconding and facing investigations..
The CIN of Sterling Biotech Limited is L51900MH1985PLC035738.
Sterling Biotech Limited is headquartered at Office No. 601, Windfall Building,, Sahar Plaza Complex, Near Hotel Kohinoor, (Andheri East), Mumbai, Maharashtra, 400059.
Sterling Biotech Limited was incorporated on 23 March 1985.
The current directors of Sterling Biotech Limited are
The primary industry of Sterling Biotech Limited is Manufacturing.
Sterling Biotech Limited is listed. It is listed on BSE: 512299.
The authorized capital of Sterling Biotech Limited is ₹2,800.00 Cr, and the paid-up capital is ₹643.35 Cr.
The compliance status of Sterling Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX